Literature DB >> 31545502

Knockdown of Nedd8‑conjugating enzyme UBE2M suppresses the proliferation and induces the apoptosis of intrahepatic cholangiocarcinoma cells.

Bin Zhao1, Caiyan Gao1, Daixiu Shi1, Jie Mao1, Jun Zhao1, Lingyun Guo1, Jiwu Guo1, Zuoyi Jiao1.   

Abstract

As an important regulator of neddylation, neural precursor cell expressed developmentally downregulated 8 (Nedd8)‑conjugating enzyme E2M (UBE2M) mediates cullin neddylation. Upregulation of the neddylation pathway is associated with tumor progression in intrahepatic cholangiocarcinoma (ICC). The present study was designed to assess the effects of Nedd8‑conjugating enzyme UBE2M knockdown on intrahepatic cholangiocarcinoma cells, and to determine the potential underlying mechanisms. UBE2M and associated protein expression levels were determined via immunohistochemistry and western blotting. ICC cells were transfected with short hairpin RNA to knockdown UBE2M expression. Cell Counting Kit‑8 and colony formation assays, and xenograft experiments were used to examine cell viability and colony survival in vitro, and tumor formation in vivo. Survival was evaluated using Kaplan‑Meier analysis and log‑rank tests. Patients with ICC presenting high expression of UBE2M exhibited worse accumulative recurrence and overall survival compared with patients with low expression. Knockdown of UBE2M expression led to a decrease in the viability and clonogenic survival of QBC939 and HUCCT1 cells, and suppressed tumor formation in vivo. UBE2M silencing caused accumulation of cullin‑RING ligase substrates (chromatin‑licensing and DNA replication factor 1 and origin recognition complex subunit 1), inducing DNA damage responses and apoptosis. The present findings suggested that UBE2M serves an important role in ICC progression and may present as a novel target for the treatment of ICC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31545502     DOI: 10.3892/or.2019.7327

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.

Authors:  Jingrong Xian; Shiwen Wang; Yanyu Jiang; Lihui Li; Lili Cai; Ping Chen; Yue Liu; Xiaofei Zeng; Guoan Chen; Chen Ding; Robert M Hoffman; Lijun Jia; Hu Zhao; Yanmei Zhang
Journal:  Cancer Biol Med       Date:  2021-03-18       Impact factor: 5.347

Review 2.  Targeting neddylation E2s: a novel therapeutic strategy in cancer.

Authors:  Yi-Chao Zheng; Yan-Jia Guo; Bo Wang; Chong Wang; M A A Mamun; Ya Gao; Hong-Min Liu
Journal:  J Hematol Oncol       Date:  2021-04-07       Impact factor: 17.388

Review 3.  The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy.

Authors:  Xiaodi Du; Hongyu Song; Nengxing Shen; Ruiqi Hua; Guangyou Yang
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

4.  Overexpression of UBE2M through Wnt/β-Catenin signaling is associated with poor prognosis and chemotherapy resistance in colorectal cancer.

Authors:  Jianmin Xu; Guoqiang Lv; Binghua Xu; Bin Jiang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.